Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 4/2019

01-04-2019 | Opioids | Concise Research Reports

Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017

Authors: Aishwarya Vijay, BS, Joseph S. Ross, MD, MHS, Nilay D. Shah, PhD, Molly M. Jeffery, PhD, Sanket S. Dhruva, MD, MHS

Published in: Journal of General Internal Medicine | Issue 4/2019

Login to get access

Excerpt

In 2015, 38% of adults used prescription opioids, with slightly higher rates among older adults.1 Risks of opioids have been well-described and are greater among older adults and when used concurrently with three commonly prescribed “opioid potentiator” drug classes: benzodiazepines, non-benzodiazepine sedative hypnotics, and gabapentinoids.2, 3 These drugs also have risks when used on their own; in particular, there has been an increasing risk of death associated with benzodiazepine use.4 …
Literature
1.
Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health. Ann. Intern. Med. 2017;167(5):293–301.CrossRefPubMed
2.
3.
Gomes T, Greaves S, van den Brink W, et al. Pregabalin and the Risk for Opioid-Related Death: A Nested Case–Control Study. Ann. Intern. Med. 2018.
4.
5.
Samuels EA, Ross JS, Dhruva SS. Medicare formulary coverage restrictions for prescription opioids, 2006 to 2015. Ann. Intern. Med. 2017;167(12):895–896.CrossRefPubMed
6.
Metadata
Title
Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017
Authors
Aishwarya Vijay, BS
Joseph S. Ross, MD, MHS
Nilay D. Shah, PhD
Molly M. Jeffery, PhD
Sanket S. Dhruva, MD, MHS
Publication date
01-04-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 4/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4752-8

Other articles of this Issue 4/2019

Journal of General Internal Medicine 4/2019 Go to the issue

Letter to the Editor

“Comparing VA and Non-VA Care Quality”

Original Research

Cost-Effectiveness of Bridging Anticoagulation Among Patients with Nonvalvular Atrial Fibrillation

Concise Research Reports

Trends, Management Patterns, and Predictors of Leaving Against Medical Advice among Patients with Documented Noncompliance Admitted for Acute Myocardial Infarction

Original Research

Randomized Trial of Personalized Breast Density and Breast Cancer Risk Notification

Concise Research Reports

Everyday Resilience: Practical Tools to Promote Resilience Among Medical Students

OriginalPaper

Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults’ Perspectives

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits